LONDON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

(RTTNews) - Edwards Lifesciences Corp. (EW) on Tuesday said its SAPIEN M3 mitral valve replacement system received U.S. Food and Drug Administration (FDA) approval for the treatment of mitral ...

The company said it plans to present results from a pivotal trial of Sapien M3 later this year. The implant is not yet approved in the U.S. (iStock / Getty Images Plus) After acquiring its developer ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) ...

Irvine-based Edwards Lifesciences Corp.’s shares rose today on positive results from several studies of less-invasive heart valves. The company’s shares closed up 10% today to a market value of $16 ...

SAN FRANCISCO, March 10 (Reuters) - A smaller, redesigned version of Edwards Lifesciences' non-invasive heart valve replacement system called Sapien XT performed well and led to fewer complications ...

The Food and Drug Administration approved a new use for Edwards Lifesciences Corp.’s Sapien 3 artificial heart valve, reports Reuters. The valve may now be used to replace failing heart valves ...

Review staff from the US Food and Drug Administration (FDA) said Edwards Lifesciences' Sapien Transcatheter Heart Valve (THV) met trial endpoints for safety and effectiveness for the treatment of high ...

Edwards Lifesciences Corp. says it won’t go back to the drawing board after a setback on a heart valve the company sees as a growing part of its business. The issue arose after Edwards said the ...

CHICAGO, April 20 (Reuters) - Edwards Lifesciences reported quarterly earnings that increased by a third, led by strong European sales of its minimally invasive heart valve replacement system. Edwards ...